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1. Summary 
This review deals with the structure of the actin 
monomer, its assembly into filaments and the loci on 
F-actin involved in binding myosin. Two distinctly differ- 
ent arrangements of monomers have been suggested for 
actin filaments. One model proposed by Holmes et al. is 
well developed. It places the so-called 'large' domain 
close to the filament axis and the so-called 'small' domain 
out near the surface of the filament. A second, less-well 
developed, model proposed by Schutt et al. locates the 
'small' domain close to the filament axis and they rotate 
the monomer so that 'bottom' of the 'large' domain is at 
the highest radius. We analyze the available vidence for 
the models of F-actin derived from X-ray diffraction, 
reconstructions from electron micrographs, fluorescence 
resonance nergy transfer spectroscopy, chemical cross- 
linking, antibody probes, limited proteolysis, site-directed 
and natural mutations, nuclear magnetic resonance spec- 
troscopy and other techniques. The result is an actin- 
centered view of the loci on actin which are probably 
involved in its interaction with the myosin 'head'. From 
these multiple contacts we speculate on the sequence of 
steps between the initial weak-binding state of S-1 to the 
actin filament through to the stable strong-binding state 
seen in the absence of free Mg-ATP, i.e., the rigor state. 
2. Introduction 
Sir Andrew Huxley, with his characteristic sense of 
history, recently commented on the nature of research into 
contractility [1]. Simply put, he tells us that, for a century 
and a half, advances in the field of muscle research ave 
come in 10-20 year cycles. The last major high point 
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occurred in 1972 at the Cold Spring Harbor Symposium on 
Contractile Proteins where there seemed to be a consensus 
view that the molecular mechanism of contraction was, in 
principle, solved. The rotating crossbridge mechanism was 
firmly established [2] and it seemed to be a reasonable 
explanation for the relative sliding of the actin and myosin 
filaments. Sir Andrew strongly disagreed that the mecha- 
nism was solved and posed a list of important questions 
which remained unanswered [3]. Traditionally, advances in 
molecular function are accompanied by advances in molec- 
ular structure. If this is true, we are surely on the brink of a 
major advance in the field. 
1990 was a watershed year, for it produced the Kabsch 
et al. [4] structure of actin resolved at 2.8 A. Today, no 
less than four separate laboratories have completed atomic 
resolution X-ray diffraction structures of actin. The most 
recent two [5,6] were published within months of each 
other in 1993. These publications, as well as the papers by 
Rayment et al. [7,8] and SchriSder et al. [9] on the 'dock- 
ing' of F-actin with the crystal structure of myosin sub- 
fragment-1 (S-l), have been major catalysts for this re- 
view. 
3. An historic perspective of actin structure 
In 1942 F.B. Straub [10] published a 13-page paper in a 
Hungarian journal that few researchers have ever heard of 
today. In it he described the first isolation of actin from an 
acetone powder and showed that a solution of actin be- 
came viscous when divalent or monovalent cations were 
added. It was to set in train an avalanche of papers dealing 
with the in vitro and in vivo properties of actin which even 
today shows no sign of abating. Type the word 'actin' into 
a reference database and it will yield more than 1500 
papers a year. Over the years, a disproportionate number 
of these contributions have been made by Hungarian scien- 
tists around the world [11]. 
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Jean Hanson's classic paper on the structure of F-actin 
[12] described the monomers in the filaments as an helical 
array of simple spheres. This view persisted into the 60's 
and 70's with the publication of several reconstructions of
electron micrographs of actin filaments [13-15]. These 
reconstructions from electron micrographs of actin fila- 
ments and paracrystalline bundles of filaments suggested 
that the actin monomer was elongated having a large and 
small domain. Thus, the actin monomer gradually 'evolved' 
into a more complex, bi-lobed structure and much of the 
subsequent discussion (e.g., [16]) centered on whether the 
large domain was located at high or low radius from the 
filament axis, and whether the ' long' axis of the monomers 
were oriented approximately perpendicular or parallel to 
the filament axis. 
Clearly, the field needed a crystal structure and in the 
mid-70's G-actin was crystallized by Christine Oriol [17] 
in the presence of poly(ethylene glycol). Unfortunately, the 
crystals were small and apparently not suitable for analysis 
by X-ray diffraction. The tendency for actin to polymerize 
was circumvented by the formation of two-dimensional 
crystalline arrays in the presence of lanthanide ions [18,19]. 
Analyses [19,20] of these arrays suggested projected di- 
o 
mensions of 56 × 33 A. The resolution from electron 
diffraction (about 12 A) of these 2-D arrays was much 
better than the resolution achieved by negatively-stained 
images seen by electron microscopy (about 30 A), but 
these studies provided only a glimpse of the overall shape 
of the monomer, suggesting that the monomer was roughly 
' pear-shaped'. 
The first crystal (6 ,~ resolution) structure of actin was 
published in 1981 by Suck et al. [21] from co-crystals of 
skeletal muscle actin with bovine pancreatic DNase I. 
They confirmed the two domain nature of actin and ob- 
served monomer dimensions of 67 × 40 × 37 ,~. Two 
years later the Nagoya structure group published a 5 
resolution structure of smooth muscle actin, also co-crys- 
tallized with DNase I [22]. This was followed by a 5 A 
map from the Heidelberg group [23] which suggested 
dimensions were closer to 60 × 40 × 30 ~,. All the while, 
Schutt and his colleagues had been working towards a 
structure from their actin-profilin co-crystals [24]. 
Atomic structure of skeletal a-actin-DNase I co-crystals. 
Therefore, it was with considerable anticipation that we 
awaited the publication of the first atomic-resolution (2.8 
,~) structure of actin in 1990 [4]. The wait was certainly 
worth it and this structure is now accepted as the 'gold' 
standard. The view shown in Fig. 1 has become the 
conventional perspective of actin. This structure is not 
usually illustrated as a co-crystal, i.e., as a complex of two 
distinct proteins, but it is worth keeping in mind that there 
is an ever-present but 'invisible' DNase I bound to the 
'top'  of the actin monomer. Their actin was isolated from 
rabbit skeletal muscle and it was mildly digested with 
trypsin to remove the C-terminal three residues to facilitate 
crystallization [25]. Two assumptions were made. The first 
D288 ooau 
Fig. L A ribbon diagram of the three dimensional atomic structure of the actin monomer shown with approximately the same orientation as originally 
illustrated by Kabsch et al. [3]. This actin structure was obtained from co-crystals of actin-DNas¢ I from which the DNase ! component has been removed. 
The solid line represents the separation of the so-called 'large' (left) and the 'small' (right) domains. The broken lines indicate the subdivisions of these 
domains into the four subdomains indicated by the numbers. Representative amino acid residues have been umbered so that he loci of interest in the text 
can be identified. 
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was that the actin 'conformation' is not significantly al- 
tered by the bound DNase I [26], even though some 
structural modification was inevitable given the magnitude 
of the association constant (K a 5 X 108 M 1). The second 
assumption was that there are only minimal conforma- 
tional changes in the actin molecule when moving from 
the actin-DNase I complex to the protomer in F-actin. Both 
assumptions seem to be largely correct. 
There were some surprises in the Kabsch et al. model. 
Rather than two domains, it had four clearly-defined sub- 
domains and a particularly strong similarity was noted 
between subdomains 1 and 3 which appear to have arisen 
from a gene duplication [27]. Subdomains 1 and 2 on the 
right side of Fig. 1 comprise the so-called 'small' domain 
which are linked to subdomains 3 and 4 (the so-called 
'large' domain) by a 'hinge' or connecting piece between 
subdomains 1 and 3. In fact the 'small' domain is not 
significantly smaller than the 'large' domain. Few had 
predicted that the N- and C-termini would be so close to 
each other, or even that they would be located in the same 
region. 
Smooth muscle actin-DNase 1 co-crystals. At Tsukuba 
in November 1992 Sakabe et al. [28] described a new 
crystal structure of chicken gizzard actin complexed with 
DNase I. It contained an intact C-terminus and was re- 
solved at 2.0 A. Although the atomic coordinates of the 
Tsukuba actin structure are not yet widely available, the 
structure is clearly very similar to the Heidelberg model. 
However, it contained some differences from the Kabsch 
et al. structure, particularly in subdomain 2 which, together 
with subdomain 4 makes contact between actin and DNase 
I. It is therefore regrettable that it has not been published. 
Some, if not all of these differences may be due to the 
different sequences of the skeletal and smooth muscle 
a-actins isoforms [29]. One difference from the Kabsch et 
al. structure was the chain tracing at the N-terminus. 
Smooth muscle a-actin has one less acidic residue and 
consequently Cys-9 is equivalent o the skeletal muscle 
Cys-10 actin. Unlike the Kabsch model, they described the 
location of Cys-374 at the 'back' of subdomain 3 instead 
of subdomain 1. This feature was consistent with modelled 
fluorescence resonance nergy transfer (FRET) distances 
in skeletal actin [30]. 
Actin-gelsolin segment 1 co-crystals. A third actin 
structure, recently announced by Mannherz et al. [31] 
involved co-crystals of actin with segment 1 of gelsolin. 
This actin structure has an intact C-terminus and was 
solved at 2.55 ,~ [5]. Segment 1 of gelsolin binds across 
the 'bottom' of actin making close contact with subdo- 
mains 1 and 3 whereas DNase I binds across the 'top' of 
subdomains 2 and 4. Despite this, the McLaughlin et al. 
actin model is very similar to the original Kabsch et al. 
structure. The actin subdomains in the two structures main- 
tain their relative orientation although the two main DNase 
I contacts are significantly more disordered in the 
McLaughlin structure which of course has no DNase I. 
Residues 40-49 have no apparent electron density and are 
presumed to be highly disordered. The rms residual be- 
tween backbone atoms of the Kabsch and McLaughlin 
structures i only 0.9 ,~ [5]. 
fl-Actin-profilin co-crystals. Schutt et al. have now 
reported the fourth and most recent actin structure. They 
co-crystallized a /3-actin-profilin complex, both derived 
from bovine spleen, and solved the actin structure at 2.55 
,~ resolution [6]. Gelsolin segment 1 and profilin bind to 
the same region of the actin monomer. Their monomer 
structure strongly resembles the Kabsch et al. structure, 
particularly in subdomain 3 where the a-carbons align 
o 
with an rms deviation of only 0.495 A. The 39-52 has a 
clearly resolved structure because it is stabilized by the 
crystal contacts between adjacent actin monomers. The 
C-terminus (which was not cleaved prior to crystallization) 
is located in a pocket close to the N-terminus in subdo- 
main 1. There is an overall 5 ° rotation of the small and 
large domains and there are differences between the Schutt 
et al. and the Kabsch et al. structures, which one might 
expect given their different sequences. The co-crystals 
were made using Sr 2+ rather than Ca 2÷ as the bound 
divalent cation and this may also account for some of the 
structural differences. This profilin-actin complex forms a 
ribbon-like structure which they describe as mimicking the 
one-start left-hand genetic helix of F-actin. However, the 
validity of this interpretation is currently a matter of some 
debate (see [32,33]). 
Thus, over the past 4 years we have been blessed, 
perhaps even embarrassed, by a surfeit of actin structures. 
Today, four laboratories, in Heidelberg, Tsukuba, Cam- 
bridge and Princeton, have completed atomic-resolution 
structures of actin using a- or/3-actin isoforms complexed 
to proteins uch as DNase I, gelsolin segment 1or profilin. 
Each structure has contributed new information and a 
unified view has emerged which accords with the Kabsch 
et al. structure. Of these, the data on the smooth muscle 
actin-DNase I have been presented at a meeting [28] but 
have not yet been formally published. 
4. Act in monomer  structure 
Actin is found in virtually every eukaryotic ell. There 
are at least 103 unique sequences and all are highly 
conserved [34]. Rabbit skeletal muscle actin has become 
the standard actin with which all others are compared. It 
consists of a single polypeptide chain of 375 residues with 
a bound ADP or ATP and a single, high-affinity divalent 
cation. There is little doubt that the overall structure of the 
actin monomer proposed by Kabsch et al. is correct. Only 
those extremely different isoforms (e.g., Tetrahymena actin 
[35]) with their altered amino terminal sequence may not 
comply with the view shown in Fig. 1. An understanding 
of the structure of this basic building block and of its 
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isotypic variations is an important element in our under- 
standing of the diverse biological functions of actin, and 
particularly of its interactions with the myosin head. 
Reactive cysteinyls. There are five cysteinyls in rabbit 
skeletal muscle actin, of which only three (Cys-10, Cys-257 
and Cys-374) can be modified in the absence of chaotropic 
agents uch as 6 M urea. Of these, Cys-374, which is by 
far the most reactive, has been the focus of numerous 
investigations ( ee [34] for an extensive summary). The 
least reactive are Cys-217 and Cys-285 (see [25] for a 
review of this topic). Over 10 years ago Lin and Dowben 
[36] noted that Cys-10 and Cys-374 exhibited excimer 
fluorescence and were therefore probably close to each 
other, since the excimer property was possible only if 
fluorescent probes physically stack. They also concluded 
that Cys-374 was close to, but not actually at, an S-1 
binding site. 
Publication of the Kabsch et al. 2.8 A structure of the 
actin revealed that subdomain 1 contains the N-terminus 
(residues 1-32), the C-terminus (residues 338-375) as 
well as residues 70-144. They pointed out that most of the 
published fluorescence r sonance nergy transfer (FRET) 
distances within actin were consistent with the structure, 
with the exception of Cys-10. How could FRET spec- 
troscopy of Cys-10 [37-41] produce such an artefact? We 
now know from its position in the structure relative to 
other loci that its misplacement could not have been due to 
a small fraction of probes bound at cysteinyls other than 
Cys-10 (e.g., Cys-285 or Cys-374). It was also very un- 
likely that a placement error was due to an incorrect 
assumption for the value of the orientation parameter (K 2) 
(see [42] for a detailed discussion). We therefore con- 
cluded that the structure around Cys-10 was probably 
distorted by the labelling procedure (e.g., the reaction 
conditions involved 1 M urea), particularly when large 
fluorescent labels are used. Recently, Drewes and Faulstich 
[43] suggested that the replacement of ATP by ADP causes 
a slow, reversible conformational change in actin that 
exposes Cys-10 to the solvent, thus enabling it to be 
specifically labelled. 
Aspartate 11. When this residue is changed by site-di- 
rected mutagenesis to Glu, Asn or His, the resulting actin 
can still polymerize and bind S-l, but it seems to be subtly 
changed so that it no longer migrates normally in native 
polyacrylamide gels or binds to immobilized DNase I. It 
thus seems that the /3-sheet motif in subdomain 1 is 
probably important for these properties and may also be 
essential for the proper folding of the native structure [44]. 
This residue is probably involved in a'number of cross-lin- 
king studies with S-1 (see Table 2). 
Glutamine-41. It was first labelled by Reiji Takashi 
[45]. It lies at the 'top' of subdomain 2 (Fig. 1) and we 
recently undertook a series of FRET determinations of the 
distance between this residue and Cys-374 in the presence 
and absence of DNase I [46]. We found that the distance 
between Gln-41 and Cys-374 increases when DNase I 
binds. Other FRET measurements showed that the Tyr-69- 
Cys-374 distance was not significantly altered by DNase I 
binding [47]. Taken together, this suggests that the mobile 
DNase I-binding loop at the top of subdomain 2 (residues 
39-52) may occupy different positions in the free monomer 
and F-actin. Such a change is consistent with the fact that 
subdomain 2 is one which was most changed in construct- 
ing the Holmes et al. filament model. 
Lysine-61. Modification of the side-chain of this residue 
with a fluorescent probe [48] or an 19F-NMR probe [49] 
greatly reduces the ability of the monomer to self-assem- 
ble, suggesting that it may lie at or close to an actin-actin 
contact site. This residue is also a contact point for the 
interaction of G-actin with DNase I [4]. Labelling is per- 
turbed by the presence of S-l, but it may not represent a 
true actin-myosin contact point. The distance between this 
locus and Cys-374 does not change during polymerization, 
association with S-I, or binding DNase I. This suggests 
that overall, the structural relationship between subdo- 
mains 1 and 2 does not alter [48]. 
Tyrosine-69. Modification of this residue with the fluo- 
rescent label dansyl chloride [50-52] produces effects 
similar to the labelling of the nearby Lys-61. It is possibly 
an actin-actin contact site and it is also a contact site for 
DNase I [4]. Miki and Kouyama [53] recently showed that 
the distance between a fluorescent probe attached to this 
residue and the nucleotide-binding site in G-actin (25-27 
A) decreased (22-23 ,~) upon polymerization. 
Arginine-177. This is the one of the rare loci in the 
'large' domain of actin which can be specifically labelled 
[54,55]. It is also one of the sites of contact between actin 
and phalloidin which stabilizes the filament structure by 
binding between two adjacent monomers [56]. 
The role of the nucleotide and divalent cation. There 
are several features of the atomic structure of actin which 
are of particular interest for the actin-myosin i terface. In 
the ribbon diagram (Fig. 1) there appears to be a prominent 
cleft between the large and small domains and while much 
attention has been paid to this cleft it is barely discernible 
when viewed as a space-filling model [27]. The junction 
between these domains is confined to the bend at the 
beta-sheet-helix segment near residue 137, and the 331-338 
loop. This suggests that the large and small domains are 
joined by a 'hinge' allowing limited movement of the cleft 
with its bound nucleotide. The modes of motion of the 
large and small domains in G-actin were recently de- 
scribed as a 'propeller-like' opening-closing flexure [57]. 
Binding of myosin to F-actin promotes the exchange of 
actin-bound nucleotide [58,59] and it is probable that the 
modulation of the nucleotide cleft may be a functionally 
important feature of actin. The binding of DNase I reduces 
the rate of exchange of nucleotide probably because it 
bridges the gap between subdomains 2 and 4. Several other 
actin-binding proteins, including profilin, actin depolymer- 
izing factor and thymosin /34, can alter the rate of nu- 
cleotide exchange [60] . These probably modulate nu- 
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cleotide exchange by inducing an opening and closing of 
the cleft. 
The nucleotide-divalent metal ion complex (usually 
ATP-Ca in G-actin, mainly ADP-Mg in F-actin) resident in 
this cleft probably stabilizes the two domains and main- 
tains the native conformation of the monomer by making 
contact with all four subdomains. The rate of nucleotide 
exchange in the monomer is about 1000-fold faster than in 
actin filaments [61]. A considerable literature xists on the 
nature of the conformational differences between these 
monomers and on the structural changes that occur when 
actin monomers are studied under elevated salt conditions. 
This literature has been reviewed elsewhere [25]. Its rele- 
vance here is that in the Holmes et al. [62] filament model 
it was assumed that the monomer structure in F-actin and 
G-actin may be very similar. 
The nucleotide seems to stabilize the monomer by 
making contact between all four subdomains. Nucleotide 
exchange is rapid in G-actin and very slow in F-actin. It is 
possible to assemble F-actin from monomers which en- 
tirely lack a bound nucleotide [63], but under normal 
conditions actin rapidly denatures once the nucleotide is 
removed. 
A change in the bound nucleotide from ATP to ADP 
does not contribute to the energy of actomyosin i teraction 
[64], but the state of the bound divalent cation-nucleotide 
complex is thought to have substantial effects on the 
structure of the actin filaments, the rate of nucleotide 
exchange and the structural rigidity of actin filaments [65]. 
These findings were recently challenged by Pollard et al. 
[61] and the differences, although not resolved, were as- 
cribed to the actin preparations, e.g., the Pollard laboratory 
researchers do not freeze their actin preparations. Ex- 
change of ATP for ADP in G-actin causes a slow opening 
of the /3 sheet motif in subdomain 1 [43] which is reversed 
by ATP. 
The question of the involvement of the nucleotide in the 
flexibility changes in the filament was investigated by 
others. It now seems that the changes may be attributed to 
the type of bound divalent cation and that the effect is 
cooperative [66]. Ca 2÷, phalloidin and inorganic phosphate 
cause a slight closing of the nucleotide cleft and a reduc- 
tion in the filament diameter while Mg 2÷ and DNase I 
binding have the opposite ffect [34]. 
Tropomyosin stabilizes the actin filaments, significantly 
decreasing their flexibility [67] in solution. It also slightly 
reduces the rate of nucleotide exchange and markedly 
reduces the release of actin-bound nucleotide [68]. Recent 
FRET data suggest that the binding of tropomyosin- 
troponin to F-actin reduces the mobility of the nucleotide 
in its cleft [53]. The binding of myosin to F-actin also 
increases the flexibility of F-actin [67] and it is likely that 
it does so by modulating the flexing of the large and small 
domains. Binding of a myosin head to F-actin may open 
the nucleotide cleft and facilitate the observed release of 
actin-bound ADP [58,59]. If, as Holmes et ai. propose, the 
large domains bind to each other across the filament axis, 
their positions would be stabilized. This would probably 
result in an intramonomer movement of the small domain 
to a larger radius, i.e., away from the fixed larger domain. 
Such a notion could be tested by FRET experiments with 
probes on the large and small domains. 
Fluorescence quench experiments have been informa- 
tive here. Root and Reisler [69] suggested that the binding 
of S-1 induces different changes from those produced by 
Mg 2÷ induced polymerization. S-1 binding reduces the 
accessibility of etheno analogs of ATP to quenchers 
whereas, it increases with Mg-induced polymerization. 
This S-1 effect is independent of the polymer state of 
actin. 
Hegyi et al. [70] attached a photoaffinity-labelled ana- 
log of ATP at the nucleotide-binding site and identified 
Lys-336 and the peptide 356-359 as cross-linked products. 
tt~L Two-start 
~/  ° ngghittchaHd~id e s 
Single-start 
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\CTIN 
Fig. 2. F-actin can be viewed as a single helix (the so-called 'genetic' 
helix) which is a single-start, left-handed helix passing through the 
monomers 1 through 6. This helix is indicated by the white arrows and 
involves arotation of the monomer through approximately 166 °and a rise 
(or translation) of 27.5 ,~. The filament can also be considered tobe a 
two-start, right-handed helix with a half pitch of 350-380 A. The 'back' 
strand on each elix is shaded. 
104 C.G. dos Remedios, P.D.J. Moens / Biochimica et Biophysica Acta 1228 (1995) 99-124 
In the Kabsch et al. model, Lys-336 lies on a loop at the 
bottom of the nucleotide cleft, but 356-359 is near the 
N-terminus, well removed from this location. Perhaps the 
356-359 peptide is related to the putative second nu- 
cleotide binding site [71]. 
Thus, although the form of the nucleotide bound in the 
pocket of actin may not be critical to the function of actin, 
its very presence may play a crucial role in the mainte- 
nance of a native conformation and it is probable that 
some flexing of the domains and subdomains i important 
for S-1 binding, for tropomyosin regulation, for the control 
of actin assembly, and for its regulation by actin-binding 
proteins. 
5. The structure of F-actin 
If we are to understand the finer details of the structure 
of the acto-myosin i terface, it is important to know how 
the actin monomer is oriented in the filament. F-actin, of 
course differs from muscle thin filaments in that the latter 
contain other proteins, notably tropomyosin and the tro- 
ponins. Fig. 2 is a cartoon of the two most commonly 
described helices in F-actin. The single-start, left-handed, 
short-pitch genetic helix has an angular otation of about 
166 ° of one monomer with respect to the next and a 
translation of 27.5 A [72]. The two-start, right-handed 
long-pitch elices have a pitch of about 750 A. Cryoelec- 
Fig. 3. A stereo pair representation f the C~,-positions of amino acid residues and their helical arrangement of monomers in F-actin showing the 'small' 
domain at large radius. This model of F-actin was reported by Holmes et al. [29] and emphasized the contacts between monomers along the two-start 
long-pitch elices (reproduced with permission). 
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tron microscopy of rapidly frozen F-actin has a diameter of 
about 100 A [73]. Before the publication of the Holmes et 
al. model, discussion on the structure of F-actin centered 
on two questions. What is the orientation of the monomer 
in the filament? Are the main contacts stronger between 
monomers along the genetic helix or along the long-pitch 
helix? Today there seems to be a consensus that the 
Holmes model or a modification of it is widely accepted. 
Even so, it seems worthwhile to review the evidence for 
and against his model. 
Electron microscopy perhaps has muddied rather than 
clarified our view of F-actin structure. Some reports em- 
phasized monomer-monomer contacts along the single- 
start, left-handed genetic helix [74-80] while others 
[16,73,81] favored the contacts along the two-start, long- 
pitch helix. It was really not until the monomer structure 
was published that progress was made in interpreting the 
structural data. 
Two models of  F-Actin. The development of the 2.8 
resolution X-ray diffraction structure of actin enabled 
Holmes et al. to construct a detailed model of the actin 
filament [62] which was consistent with fiber diffraction 
data from their flow-aligned phalloidin-F-actin [82,83]. 
The resolution of these data was 8 A and the best fits of 
the monomer structure to the fiber data were obtained by 
orienting the long axis of the monomer oughly perpendic- 
ular to the filament axis and by positioning the large 
domain (comprising subdomains 3 and 4) close to the 
filament axis while permitting some degree of independent 
motion of each of the four subdomains of actin. Subdo- 
'1 
Fig. 4. A stereo pair image of the actin-profilin ribbon showing the peptide backbone structure of both proteins. In this model the small domain is 
positioned closer to the filament axis than the large domain and the actin monomer is approximately the reverse of that illustrated inFig. 1, namely with 
the 'small' actin domain close to the filament axis. At the bottom right-hand side of each image is a single monomer-profilin complex with the actin-bound 
nucleotide located in the cleft between the large and small domains. The profilin makes extensive contact with subdomains 1 and 3 and there is an 
additional major contact with subdomain 4 in the ribbon structure (reproduced from [26] with permission). 
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Fig. 5. illustrates the contact sites between the Kabsch et al. actin monomer structure and other monomers in the filament (Fig. 5a) or with myosin S-1 
(Fig. 5b). Fig. 5a represents he monomer-monomer contact sites in F-actin as summarized in Table 1. The solid ribbons represent the contact sites and the 
white numerals indicate the residues which start and finish these contacts. Note that nearly all of these sites are located on the 'back' surface of the 
monomer. Chemical cross-linking studies have shown that Gln-41 is 10.7 A from Lys-ll3 on the suprajacent monomer, and that Cys-374 is approximately 
8-14 A distant from Lys-191 on a subjacent monomer (see text). The hydrophobic loop (residues 264-273) is thought to insert between monomers on the 
opposite long-pitch strand (29,137). These actin-actin contacts are summarized in Table 1. Fig. 5b shows the contact sites between actin and myosin (S-1). 
The white numerals in the black circles are the putative contacts between actin and the myosin heavy chain (see Table 2 for full details). The black 
numerals in the white circles are the putative contact with the myosin light chains. Residues 39-52 and 360-374 probably make contact with myosin light 
chain 1 whereas residues 61-69 are thought o contact myosin light chain 2. Table 2 contains ome actin-myosin contact sites which have not been 
incorporated into this figure because they are only described as probable or possible contacts. The Table also contains loci which are on the 'back' surface 
of the actin structure and are therefore difficult to illustrate from this perspective. 
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mains 1 and 2 were located at high radius and formed a 
pronounced bulge in a plane roughly perpendicular to the 
filament axis. Subdomain 2 had to be modified by as much 
o 
as 6 A, but the other subdomains required relatively small 
(1-2 ~,) shifts [25]. The largest deviations occurred in the 
39-52 loop [84]. This makes a strong contact with DNase I 
in the co-crystal and others have argued that it is an 
important actin-actin contact in the filament [85]. 
The refined structure of the monomer in the Holmes 
filament model [62] differs from the G-actin-DNase I 
structure by an rms value of about 3 A. The major contacts 
between monomers is along the two-start, long-pitch helix 
rather than along the genetic helix. This arrangement is 
reproduced in Fig. 3 which shows subdomains 3 and 4 
located close to the filament axis while subdomains 1 and 
2 are at high radius near the surface of the filament. In 
constructing their model, the monomers were permitted 
free rotation with respect o the filament axis until a single 
best fit was obtained. Their best model was better than a 
cohort of other potential structures, but it was not unique. 
Thus, Holmes et al. have provided us with a detailed 
model of the actin filament which we now can use to 
compare with data from a variety of other sources. 
Other models of F-actin [84,86] differ subtly from the 
1990 Holmes structure. Lorenz et al. [84] altered the actin 
structure, particularly in the DNase-binding loop and they 
changed the orientation of the monomer to improve the fits 
to the highest resolution fiber diffraction amplitudes. Other 
variations on this theme are possible. 
However, the proposal suggested in 1993 by Schutt and 
his colleagues [6] is radically different because it dramati- 
cally changes the orientation of the monomer, strengthens 
the contacts along the single-start left-handed genetic helix 
and distorts the monomer structure to allow two-start 
contacts to be made. Their model is based on the similarity 
of the intermolecular contacts in the ribbon structure seen 
in the actin-profilin crystals as well as on the physico- 
chemical resemblance of the actin-actin contacts in the 
crystal to the interfaces found in other oligomeric com- 
plexes. In this model, subdomain 1 is located closest o the 
filament axis while subdomains 4 is placed at the highest 
radius and near the filament surface. They propose that the 
ribbon structure is actually an extended and untwisted 
form of F-actin. Schutt et al. have not yet formally pro- 
posed a model, but rather have suggested a means of 
constructing a filament [6,24]. At this stage, although they 
have revealed some features of their model (personal 
communication), the molecular coordinates of the 
monomers in the filament and the precise residues in- 
volved in their actin-actin contact sites are not yet avail- 
able. This ribbon form of actin-profilin structure is shown 
in Fig. 4. 
Calculation of diffraction layer lines from electron mi- 
crograph images. Recently, Mendelson and Morris [87] 
calculated the non-equatorial diffraction layer lines of F- 
actin derived from electron micrographs which, although 
of lower resolution, contained both phase and amplitude 
information rather than only the layer line amplitudes 
obtained from the X-ray patterns. They analyzed: (i) un- 
stained F-actin in vitreous ice [73] obtained in the absence 
of stabilizing phalloidin; (ii) negatively-stained straight- 
ened, single actin filaments [79,81]; and (iii) actin fila- 
ments in single layer actin-tropomyosin paracrystals from 
which the putative tropomyosin was removed [16]. The 
Mendelson-Morris comparisons were most interesting. The 
best fits 'nearly unanimously favored' a monomer orienta- 
tion having a long-pitch connectivity close to that de- 
scribed by Holmes et al. [20]. Only when the resolving 
power was comparatively low were fits obtained for a 
monomer connectivity along the genetic helix. 
Modelling of FRET data. We [30] adopted a different 
approach using structural information based on the known 
geometry of the actin helix and distances derived from 
FRET spectroscopy. These analyses combined data from 
intra-monomer and inter-monomer loci, with data from 
chemical cross-linking experiments. Three orientations of 
the monomer in the filament were obtained which were 
clearly better than the 182 initial possible structures. The 
labelled loci included Cys-10, Lys-61, Tyr-69, Cys-374, 
two parts of the bound nucleotide, and divalent metal sites. 
All were assumed to reside within the small domain. 
Coincidentally, when all of these loci were modelled they 
nearly lie in a single plane. In F-actin, the radius of the 
small domain was estimated to be about 26 ,~ by electron 
microscopy [73] and about 18 A from X-ray diffraction 
[62]. These values compared well with the centroids of 15 
A, 18 A and 19 A for our three monomer orientations 
derived from FRET loci. 
Monomer-monomer contacts in F-actin. In F-actin, be- 
cause of its helical symmetry, there will be contacts be- 
tween any one monomer and four adjacent monomers (see 
Fig. 2). The Holmes model identified a number of proba- 
ble residues involved in the actin-actin contacts. The con- 
tacts are summarized in Fig. 5a (including Table 1). The 
actin-actin contacts along the long-pitch helix involve 
residues: 322-325 with 243-245; 286-289 with 202-204; 
and 166-169 and 375 with 41-45 (the DNase I binding 
loop). The contacts along the left-hand genetic helix are 
between 110-112 and 195-197, and there is an additional 
hydrophobic 'plug' (residues 264-273) which we discuss 
below. As Hennessey et al. pointed in their comprehensive 
review of the molecular genetics of actin [27], these eight 
regions of the sequence involve 37 amino acids, of which 
only seven residues are invariant and 10 more are highly 
conserved across all actin isoforms. The least extensive 
contacts (residues 110-112 and 375) are in subdomain 1
and all of these are located on the 'back' surface leaving 
the 'front' completely unoccupied and available for inter- 
action with the myosin head (see below). The DNase I 
binding loop at the top of subdomain 2 is also a highly 
probable contact site and is common to both the Holmes 
and Schutt models. In subdomain 3, three contact sites 
108 C.G. dos Remedios, P .D J .  Moens / Biochimica et Biophysica Acta 1228 (1995) 99-124 
b 
< 
• ~, ~ "~ .~ ~ 
• ~ ~ ~-'~ ~ .=, ~ ~ ~-~ 
• ~. ~ ~ ~ .-. .-. 
.~ ~ ~= ~ ~, ~ ~ = = ~ 
o 
o< 
-~ ~o< ~ ~ ~ 
-~ ~ ~. . -  .~ .~ 
o ~ _ _  ~ ~ ~ .- 
~ E..~ -~ ~ -~ ~-~ ~ ~ - ~ . ,    -~ , , -~ .~ .~ '~ ~ ~ ~.~ ~-'~" ~, .~  ~.~" 
-~ .~o ~ '~ .~oo~o~o~'~ 
C.G. dos Remedios, P.D.J. Moens / Biochimica et Biophysica Acta 1228 (1995) 99-124 109 
=~ ~ . . . . . . . .  ~= 
t~ I ~ ~ 
~ N N 
8.~ 
vO 
• -~ = o 
o,I  
o 
=~,~ .-~ 
~~ ~ ~ ~ .~0 
t"q 
e~ , .~ 
o 
t i l t  I I  
~z z~ 
110 C.G. dos Remedios, P.D.J. Moens / Biochimica et Biophysica Acta 1228 (1995) 99-124 
overlap part of the profilin/gelsolin segment 1 binding 
site. Finally, the pair of contact sites at the 'top' of 
subdomain 4 are close to a DNase I binding locus and are 
common to both models. 
These actin-actin contact sites are no more conserved 
than other regions of the sequence. However, care must be 
taken in interpreting the value of these non-conserved 
sequences. The lack of conservation may produce func- 
tional differences between actin isoforms [88]. Some may 
preferentially bind actin-binding proteins [89], co-assemble 
into filaments, or activate the myosin ATPase activity [88]. 
Radial coordinates of F-actin determined by FRET. In 
principle, FRET is capable of determining the radial coor- 
dinates of fluorescent probes attached to adjacent 
monomers provided that these loci have been well-charac- 
terized. The calculation of a radial coordinate for Cys-374 
in F-actin was first described by Taylor et al. [90]. Since 
then, others have repeated [52,91] and modified [52] this 
method for other actin loci. For any given donor-acceptor 
probe pair, several donor-acceptor ratios must be indepen- 
dently determined and then fitted to a theoretical curve. 
The distances between FRET probes across the filament 
diameter tend to be large, often near the maximal FRET 
distances permitted by the probes (80-90 A), the probes 
are bulky (10-15 ,~) relative to the size of actin, and it is 
assumed that the labelled monomers randomly associate 
during filament assembly. However, within these con- 
straints, the FRET method should be capable of distin- 
guishing between models of F-actin. 
The radial coordinate of Cys-10 was determined to be 
23 ~, [40] which is in good agreement with the coordinate 
(26 A) predicted from the Holmes model. Gln-41 was 
reported to lie at a radius of 40-42 ,~ [45] much larger 
than predicted (24 ,~) by the Holmes model, but a 40 A 
radial coordinate also seems too large to be accommodated 
by the Schutt structure. We have recently repeated the 
determination f the radial coordinate of Gin-41 in F-actin 
assembled in the presence of phalloidin [92] and found a 
radius of 15-20 + 5 A, much closer to the radial coordi- 
nate of this residue in the Holmes model but also close to 
the radius (25 A) predicted by Schutt (Michael Royzycki, 
personal communication). 
In 1987 we erroneously concluded on the basis of 
inter-monomer FRET determinations that both Lys-61 and 
Cys-10 are located in the smaller and innermost of the two 
domains [48]. The radial coordinate of Tyr-69 was deter- 
mined to be in the range 20-40 A [52] and should be 
repeated because it is somewhat larger than the radius (11 
A) predicted by the Holmes et al. model even taking into 
account he molecular sizes of the probes. It is also larger 
than the radius predicted by the Schutt et al. model (Schutt 
et al., personal communication). The radial coordinate of 
the nucleotide site was determined to be 25 ,~ [48] and 
29-30/~ [91] both of which agree reasonably well with the 
Holmes model. However, none of these data enable us to 
distinguish between the Holmes et al. and Schutt et al. 
models. 
Clearly, it would help if new FRET sites were available, 
particularly in subdomains 3 and 4. ADP ribosylation or 
fluorescent-labelled phalloidin probes are possibilities as 
mentioned earlier. It might also be possible to use site-di- 
rected mutagenesis to introduce a new FRET probes site 
such as a new reactive cysteine into the a-helical 223-230 
segment. The highly reactive Cys-374 could either be 
genetically deleted or proteolytically removed [93]. Radial 
coordinate measurements for an engineered Cys-directed 
FRET probe at 223-230 should be very different in the 
two models. In the Holmes model this helix lies very close 
to the filament axis, whereas in the Schutt ribbon it would 
probably reside at a much larger radius. Another possibil- 
ity is to calculate the positions of existing loci using the 
Miki et al. modification of the Taylor et al. method which 
permits the determination of both the radial coordinates 
and inter-monomer distances for non-identical loci [94]. 
The radial coordinate of Cys-374 was originally re- 
poorted in 1981 by Taylor et al. to be approximately 35-45 
A [90]. This value is significantly larger than that (20-25 
/~) reported by Kasprzak et al. [91]. In view of this 
difference, we recently re-measured this radial coordinate 
using the Taylor et al. and Kasprzak et al. probe pairs. The 
results using the fluorescein (5-IAF) and eosin (5-IAE) 
confirmed a Cys-374 radius of 35-45 A [95]. However, 
the above discrepancy could not simply be related to the 
different sizes of the FRET probes used in these two 
different experiments. We therefore repeated the radial 
coordinate measurement of Cys-374 using the same probe 
pair as employed by Kasprzak using multiple molar ratios 
of donor:acceptor probes. We found that it falls at a radius 
of 17-18 A from the filament axis in phalloidin-F-actin. A 
precise repeat of the Taylor et al. measurements u ing the 
same donor (5-IAF) and acceptor (eosin-5-maleimide) 
probes produced a radial coordinate of 22-27 ,~. These 
data can be reconciled with a radial coordinate of 17-27 ,~ 
if the assembly of their labelled monomers i  assumed to 
be non-random. The radial coordinate calculated for the 
yS of Cys-374 in the Holmes model is 22.5 A. Our data 
would not exclude the radius (27 A) determined from 
electron microscopy reconstructions of F-actin using un- 
decagold particles [73] attached to Cys-374. Schutt et al. 
identified a heavy atom derivative at Cys-374 in their 
ribbon model and located it at a radius of 33 A [24]. On 
the basis of these data, the new FRET radial coordinate for 
Cys-374 (~ 22 A) would have favored the Holmes et al. 
and Milligan et al. models. However, recently Schutt et al. 
have revised their identification of Cys-374 (personal com- 
munication) and now place Cys-374 at a radius of 25 ,~. 
Thus, the Cys-374 data for both F-actin models now agree 
reasonably well. 
Anti-actin antibodies. Antibodies directed against actin 
are generally difficult to generate, probably because of its 
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highly conserved primary structure. Chemical modification 
of actin often seems to break the immunological tolerance 
of the host animal [96]. One of the earliest reports of a 
monoclonal antibody came from Hambly et al. [97], but 
since then many more have been generated. For those 
inclined to try, a report by Polzar et al. [98] describes a
valuable strategy for generating monoclonal antibodies. 
The physical size of antibodies (or their Fab fragments) is
large relative to the size of FRET probes or even in 
relation to actin itself. Accordingly, conclusion based on 
antibody studies may not always yield consistent interpre- 
tations. On the other hand, these shortcomings are com- 
pensated by the high affinity and specificity of these 
probes. 
In 1987 Miller et al. [99] reported that polyclonal 
antibodies directed against he N-terminal seven residues 
react equally well with either G-actin and F-actin. This 
suggests that residues 1-7 are not located at, or even 
reasonably near, an actin-actin binding site. More recently, 
Moncman et al. [100] generated a series of monoclonal 
antibodies directed against specific sequences in actin. One 
of them, which bound to and disrupted actin filaments, was 
directed against residues 68-93. This region of actin is 
sensitive to chemical modifications e.g., of His-40, Lys-61 
and Tyr-69 which also inhibit actin assembly (see [101] for 
a review). This antibody would interrupt an actin-actin 
binding contact (residues 87, 91, 92) in the Holmes model, 
but it would also interfere with actin-actin contact sites in 
the Schutt et al. filament structure. Another antibody spe- 
cific for Gln-360 (in subdomain 1) did not disrupt actin 
assembly which is consistent with both the Holmes and 
Schutt models. 
A recent report by Orlova et al. [86] studied the radial 
coordinates of an Fab fragment of the same polyclonal 
antibody reported by Miller et al. [99] to be directed 
against residues 1-7 of actin. These authors were able to 
locate only a small portion of this Fab in three-dimensional 
reconstructions of either negatively-stained or frozen-hy- 
drated actin filaments. The part they did see appeared at a 
high radial coordinate (about 40 A) and was positioned at 
a locus which did not coincide with the Milligan and 
Flicker binding site for S-1 [77]. Orlova et al. state that 
their data clearly exclude the Schutt model which places 
residues 1-7 close to the filament axis at a radius of 
13-17 ,~, i.e., at a markedly different radius (40-50 ,~) 
predicted by the Holmes model. 
Proteolysis and polymerization. Polymerization of actin 
changes its susceptibility to proteolytic digestion. The idea 
of using proteolysis to examine the interactions of actin 
was first used by Jacobson and Rosenbusch in 1976 [102]. 
They showed that one of the chymotrypsin cleavage sites 
is on the N-terminal side of both Lys-68 and Val-45. In 
addition, trypsin cuts between Tyr-69 and Gly-63 and the 
major (32 kDa) fragment retained its ability to bind ATP 
[102]. In 1975 Muzbeck et al. demonstrated that actin is 
cleaved by thrombin at Lys-113 and also at Arg-28-Ala-29 
and at Arg-39-His-40 [103]. Later, it was confirmed that 
thrombin cuts at Lys-l l3 [104] and others showed that 
subtilisin makes a unique cleavage between Met-47 and 
Gly-48 such that the products do not separate under non- 
denaturing conditions. Such cleaved actins polymerize 
more slowly and have a higher critical concentration [105]. 
However, when the N-terminal fragment was removed and 
the undigested core purified, it completely failed to assem- 
ble in the presence of high salt (Kiessling et al., personal 
communication). Konno [106] described the production of 
a chymotryptically 'split actin' which was cleaved between 
Met-44 and Val-45 without loss of residues, but he found 
no evidence that the cleavage interfered with its ability to 
polymerize. 
A specific proteinase from E. coli A2 strain cuts at 
Gly-42-Val-43 [85] right at a critical actin-actin contact 
site, and prevents alt-induced polymerization a d DNase I 
binding [107]. Recently, Hanna Strzelecka-Golaszewska 
and her colleagues [108] showed that both DNase I binding 
and polymerization of subtilisin or the E. coli proteinase 
cleaved actins are restored by substituting the bound Ca 2÷ 
with Mg 2÷. Their work has highlighted the importance of 
the bound divalent cation in maintaining the structure of 
this region of the actin monomer. An unexpected result 
was reported by Fievez and Carlier [109] who showed that 
the highly specific ArgC proteinase cleavage at Arg-39- 
His-40 is protected in G-actin but is susceptible in F-actin. 
The reverse is true for subtilisin, trypsin and o~-chymo- 
trypsin. 
The above findings suggest here is a conformational 
change in subdomain 2 between G- and F-actin. Residues 
42-43 and 47-48 and possibly residues 44-45 seem to be 
critical for actin assembly. All are at the actin-actin contact 
sites in the Holmes F-actin model. 
Chemical cross-linkers. Chemical cross-linkers react 
with residues that are physically close to each other, but 
they can also 'capture' residues that are only transiently in 
contact but which otherwise might be more separated. 
Such cross-linkers have been used for over 15 years. 
Knight and Offer [110] demonstrated that the 12-14 A 
long chemical cross-linker, N,N'-p-phenylene dimaleimide 
(p-PDM), can generate a series of cross-linked oligomers 
in the absence of S-1 but not in its presence. This same 
cross-linker can stabilize dimers that make contact either 
across the strands of the two-start helix [111] or between 
monomers along the long-pitch helix [112]. These latter 
experiments suggested the distance between Cys-374 on 
one monomer and Lys-191 on an adjacent monomer is 
about 8 ,~ [113] to 14 A [112]. These dimensions are 
somewhat less than 20 ,~ predicted from the Holmes 
F-actin and we do not know how this distance might 
constrain the Schutt filament. 
In 1992 Hegyi et al. [114] reported that at least 90% of 
the bifunctional cross-linker (N-(4-azidobenzoyl)putres- 
cine) could be linked to Gin-41 in G-actin, but that F-actin 
would not react. They showed that when these reacted 
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monomers were polymerized, the 10.7 ~, long cross-linker 
attached to Gin-41 on one monomer reacted with Lys- l l3 
on an adjacent monomer. This distance can be comfortably 
accommodated by the Holmes et al. F-actin model. 
NMR. Proteins as large as actin are difficult to examine 
by proton NMR spectroscopy. We covalently attached a 
19F label to both Cys-10 and Cys-374 and showed that the 
Cys-374 label was completely broadened when this actin 
was polymerized but that the same label attached to Cys-10 
was not broadened. We concluded that Cys-374 but not 
Cys-10 was located at an actin-actin contact site in the 
filament [115]. This conclusion was supported by Holmes 
et al. the following year. 
Site-directed mutants. The ability to introduce either 
single or clusters of amino acid substitutions (or deletions) 
at pre-determined residues in the actin sequence is a 
powerful tool. Such mutants can be expressed in yeast 
haploid segregants which have a single actin gene. These 
mutant yeasts may be temperature s nsitive, they may be 
lethal (either recessive or dominant), or have no effect on 
the phenotype. Now that we have atomic structures for a 
variety of actin isoforms, these mutants can provide in- 
sights into the importance of particular esidues. Wertman 
et al. substituted uncharged alanine residues for small 
clusters of two or three charged residues [116]. They found 
that many of the lethal mutants removed charged residues 
proposed by Holmes et al. to be involved along the 
two-start helix actin-actin binding sites. The literature on 
this topic has been extensively reviewed by Hennessey et 
al. [271 
The hydrophobic loop. A feature of the Holmes et al. 
model is the hydrophobic loop or 'plug' comprising 
residues 262-272 which in F-actin extends across the 
filament axis and inserts into a hydrophobic pocket be- 
tween adjacent monomers. This element is an important 
stabilizing factor in their model. Schutt et al. have ana- 
lyzed the stability of this region and have questioned the 
plausibility of this 'plug'. This idea was tested by Chen et 
al. [117] using a site-directed mutant which substituted 
Leu-266 for a Glu-266. They found that the mutant actin 
assembled nearly normally at room temperature but had a 
10-fold increase in critical concentration at4°C reflecting a
slower nucleation of the polymer. This temperature s nsi- 
tivity provided strong support for the Holmes et al. model 
and would be consistent with the Schutt et al. model only 
if the Lys-266 to Glu-266 mutation induced conforma- 
tional changes in subdomain 2 and/or 4. Chen et al. did 
observe some global conformational changes (detected by 
changes in ellipticity at 222 nm), but they were described 
as 'minimal'. On balance, their data supported the Holmes 
model, but were insufficient to contradict the Schutt model. 
In a recent discussion of the merits of these two atomic 
models the Schutt laboratory proposed that the question of 
the orientation of the actin monomer might best be settled 
by experimentation. Cys-272 in thymus /3-actin may be 
able to be labelled and its radial coordinate determined by 
FRET and its position confirmed by image reconstructions 
of frozen hydrated F-actin or by FRET spectroscopy. 
Phalloidin. This is a cyclic heptapeptide produced by 
Amanita phalloides, a toxic mushroom. Phalloidin binds 
only weakly to G-actin, but when it binds to F-actin it 
causes a substantial stabilization of the filament and a 
30-fold decrease in the critical concentration [118]. We 
[95,119-121] and many others have used phalloidin to 
induce polymerization i modified actins which otherwise 
would not assemble, or to stabilize actin filaments, e.g., for 
in vitro motility experiments [122] and for electron mi- 
croscopy [73] and X-ray diffraction [83] observations of 
F-actin. Actin modified at His-40 [123], Lys-61 [124] or 
Tyr-69 [50] will not polymerize in the absence of phal- 
loidin. Other modifications of actin amino acid side-chains 
will assemble, but they may not always do so randomly. 
Recently we employed phalloidin to alter the assembly 
characteristics of polymerization-competent actin labelled 
at Cys-374. Phalloidin altered the assembly from a non- 
random association to an apparently random one [95]. 
Cys-10 and Cys-374, both at the 'back' of subdomain 
1, have been implicated in the binding of phalloidin [125]. 
Ken Wertman and his colleagues [56] recently used a 
series of site-directed mutants of yeast actin to demonstrate 
that when two residues were changed from charged to 
non-charged (alanyl), there was a complete loss of phal- 
loidin binding without loss of assembly. They concluded 
that the Arg-177 and Glu-179 residues are directly in- 
volved in phalloidin binding. Arg-177 is also the site of 
modification of actin when it is ADP-ribosylated using 
[126] Botulinum C2 toxin, a modification which prevents 
polymerization and disorganizes actin filaments. Both pa- 
pers suggest hat the 'back' surface of the junction be- 
tween subdomains 3 and 4 in actin are important for actin 
assembly, and both are consistent with the Holmes et al. 
model. It would be interesting to determine the radial 
coordinate of fluorescent phalloidin because the Arg-177 
will have a significantly smaller radius in the Holmes 
model than in the Schutt model. 
Angular disorder and monomer rotation in F-actin. 
Egelman and DeRosier [74] described a cumulative angu- 
lar disordering of monomers along the long-pitch helix 
which suggested that F-actin is a dynamically flexible 
rather than a rigid structure. They suggested that this arose 
from actin-actin contacts that were predominantly made 
along the genetic helix rather than the two-start long-pitch 
helix. Others have shown that some degree of rotation of 
monomers about the filament axis is possible during con- 
traction [127] and that cross-linkers such as glutaraldehyde 
interfere with the ability of HMM to move F-actin in a 
motility assay [128]. All of this suggests that the changes 
in the orientation of the actin monomer in F-actin is 
probably important for its interaction with myosin. 
Conclusions. For the time being, the question of the 
arrangement of the actin monomers in F-actin remains 
open. The intcrnational community has generally embraced 
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the Holmes et al. model of the actin filament [20] although 
it continues to undergo refinements [79,84]. The Mendel- 
son and Morris [87] analysis of the electron microscopy 
and X-ray diffraction data suggests that the original Holmes 
et al. is the most preferred model provided that the 40-49 
DNase I binding loop is modified. The molecular coordi- 
nates of the Holmes model are now widely available and 
laboratories can now carry out structural studies and test 
their data against he model distances. Much criticism has 
been levelled at the apparent lack of experimental evidence 
to support for the Schutt et al. model. Such debate [32,33] 
can be healthy so long as the issues are resolved in an 
objective and scientific manner. Clearly, what is needed is 
for Schutt and his colleagues to publish the complete 
molecular coordinates of their model. This would allow the 
replacement of the present speculative and sometimes 
heated discussion by an experimental evaluation of what 
otherwise will remain an interesting argument. 
There is little evidence for large-scale changes within 
monomers during either polymerization or during the inter- 
action of actin with myosin~ However, there is strong 
evidence for smaller (e.g., 4 A [53]), more subtle changes 
induced when actin polymerizes (particularly in subdomain 
2) and when it bind protein ligands [46,84,129,130]. These 
structural changes may be propagated along the filament 
and thus affect the binding of more remote myosin heads. 
6. Actin and the actomyosin interface 
The major function of actin in muscle cells is to cooper- 
ate with myosin in the generation of force. While this 
phenomenon is found in practically all eukaryotic ells, the 
precise role of actin in this interaction is not yet fully 
understood. Most myosins have two 'heads' or S-1 moi- 
eties each of which can independently bind to F-actin. The 
discovery of single-headed myosin suggested that two 
heads are not necessary for force development and a series 
of elegant experiments have demonstrated that S-1 alone 
can generate thin filament motion (see [131] for a review 
of this field). Nevertheless, the presence of the second 
head on myosin may improve the efficiency of the contrac- 
tile process, perhaps by inducing cooperative changes in 
the conformation of monomers 'trapped' between the 
heads. We must also consider at least two states of 
actin-myosin binding: the so-called high affinity binding 
state in the absence of ATP (the rigor state); and the 
low-affinity binding that occurs in the presence of Mg-ATP. 
No doubt there are others [132]. 
In 1982 Kazuo Sutoh published a paper entitled 'Identi- 
fication of myosin-binding sites on the actin sequence' 
[133]. It was the first to identify specific residues in the 
actin sequence involved in the rigor complex with myosin 
S-1. This seminal work used a zero-length cross-linker 
followed by cyanogen bromide or hydroxylamine cleavage 
to identify residues 1, 2, 3, 4 and 11 as the likely sites at 
the N-terminus which were cross-linked to the junction of 
the 20-50 kDa part of the myosin S-1 heavy chain. 
Binding was achieved in the absence of MgATP, i.e., 
under rigor conditions. Sutoh also found that residues 360, 
362 and 363 near the actin C-terminus were cross-linked to 
the myosin light chain 1. This region did not bind myosin 
light chain 2 or the myosin heavy chain. Had the Kabsch 
actin structure been available in 1982 it would have been 
obvious that these two apparently disparate regions were 
structurally related. Indeed, they both turned out to be on 
opposite sides of subdomain 1. It was an excellent piece of 
detective biochemistry, but was it complete? With an 
actin:S-1 ratio of 1:1 [134] it was difficult to imagine how 
this short, mobile segment could make contact with more 
than one myosin heavy chain. However, evidence was 
gathering [135] suggesting that two adjacent monomers in 
F-actin make contact with one S-1 in the absence of ATP. 
Here we have assembled the relevant contributions which 
impinge on this question. 
Ant ibody studies. Antibodies have been used in several 
studies to establish that myosin makes contact with the 
N-terminus of actin. Studies with affinity purified poly- 
clonal antibodies directed against he N-terminal 1-7 ini- 
tially suggested that the contact between these residues and 
S-1 may be of secondary importance. In the absence of 
MgATP, these antibodies eemed to have little effect on 
the 'strong' binding of S-1 to F-actin [99]. 
Subsequent studies showed that these same antibodies 
block the 'weak' binding of S-1 observed in the presence 
of bound MgATP, i.e., during catalysis. At equimolar 
ratios of Fab and S-I, the actin-activated myosin ATPase 
activity is inhibited by about 80% [136]. A similar result 
was obtained for antibodies directed against residues 18-29 
[137]. Interestingly, a cooperative ffect was observed 
where the binding of antibody to one monomer facilitates 
the binding of S-1-MgATP to neighboring monomers [138]. 
Thus, there is little doubt that residues 1-7 are somehow 
involved in binding of S-1. At the same time, there was no 
evidence that this acidic N-terminus is important for the 
polymerization of actin [139]. 
Anti-actin antibodies affinity-purified so that they are 
directed against residues 18-29 of rabbit skeletal actin had 
no effect on the binding of S-1 in the absence of ATP 
[137]. In the presence of MgATP their binding was strongly 
inhibited in a similar way to the binding of antibodies to 
the N-terminal 1-7 residues. However, antibody binding to 
18-29 did not alter the binding of antibodies directed 
against residues 1-7. These authors therefore concluded 
that the effects of the two antisera were similar but sepa- 
rate. 
The affinity-purified anti- l-7 polyclonal antibodies de- 
scribed by Miller et al. [99] was recently visualized on 
actin filaments [86]. Three-dimensional reconstructions vi- 
sualized only a fraction of the Fabs bound to the filament 
at a high radius not far from the convex surface of S-1. 
This observation is consistent with the notion that the 
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mobile N-terminus of actin which protrudes from the 
surface of the monomer [96] and may act as a mobile 
'guide' for docking with S-1 which subsequently makes a 
high-affinity (i.e., more extensive) contact with a substan- 
tial surface of the small domain of actin [130]. Once this 
guiding function is over (e.g., in the presence of free 
MgATP), the N-terminus of actin may release its contact 
with S-1 and thus be available for binding to other ligands. 
It is probably also responsible for the actin-activation of
myosin ATPase activity. 
In 1990 Labbe et al. [140] reported a competition 
between S-1 and an anti-actin antibody specific for an 
epitope which included Thr-103. More recently, they [141] 
concluded that there were two topologically distinct loci 
on actin which bind myosin S-1 under rigor conditions: (i) 
near the N-terminus namely sequences 1-7,  21-29, 77-95 
and 96-103 on the 'front' surface of subdomain 1; and (ii) 
the sequence 112-125 and 360-372 on the opposite sur- 
face of subdomain 1. This is consistent with their earlier 
observations that two adjacent actin monomers bind to a 
single S-1 heavy chain. Using sets of antibodies directed 
against short peptides, they concluded that the sequences 
from 96-103 and 112-132 represent distinct and different 
loci. 
Proteolysis of actin when bound to S-1. In 1986 [142] 
we suggested (but could not have known) that the prote- 
olytic fragments of actin did not correspond to structural 
domains. It was not until 1990 that the Kabsch et al. 
structure clearly showed that the large and small domains 
of actin bore no relationship to the proteolytic 'domains'.  
Thus, proteolytic susceptibility probably reflects only the 
accessibility of loops of actin to the solvent rather than 
domains. 
Konno [106] produced a chymotryptically 'split '  actin, 
cleaved between Met-44 and Val-45, which retained its 
ability to bind S-1 in the absence of the MgATP. Under 
rigor conditions, the N-terminal fragment (residues 1-44) 
was cross-linked to S-1 by carbodiimide suggesting that all 
of the contacts on actin involved the first 44 residues. 
Schwyter et al. [105] used subtilisin to uniquely cut 
G-actin at Met-47-Gly-48 so that the cleavage products 
remained intact under non-denaturing conditions. They 
observed that the rate of cleavage was slower when S-1 
was bound. Under low salt conditions, the affinity of the 
cleaved actin for S-I decreased by an order of magnitude, 
but the cleavage had no significant effect on the actin- 
activated ATPase activity. Significantly, these subtilisin- 
cleaved actin filaments inhibited thin filament movement 
in a motility assay also without loss of actin-activation of
S-1 or HMM ATPase activity [143]. This implied that 
separate parts of the actin sequence are responsible for 
binding and activation of the myosin head. 
E 
Fig. 6. illustrates the loci in the actin sequence which have been probed by limited proteolysis experiments. The proteolysis i effected on the N-terminal 
side of the residues indicated. Arrow A points to His-40 residue which is the site of the cut made by ArgC proteinase; The arrows labelled C point to 
residues Val-45 and Lys-68 cleaved by chymotrypsin; arrow E shows the unique cut made at Val-43 by a proteinase isolated from Escherichia coli E2 
strain; arrow N indicates a cut made by thrombin at Lys-ll3; arrow S, is the site of cleavage by subtilisin between residues 47 and 48; and the two points 
indicated by the arrows labelled T show cuts made by trypsin at residues Gly-63 and Tyr-69. Note that none of these sites of proteolysis occur at the 
boundaries between the domains illustrated inFig. 1, and that most of the sites are accessible from the 'back' of the actin molecule. 
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In 1989 Chaussepied and Kasprzak [144] demonstrated 
that S-I(A1), containing myosin light chains 1 and 2, 
promotes rapid assembly of G-actin whereas S-I(A2), with 
its bound myosin light chains 2 and 3, does not. Chen et al. 
[145] reported that S-I(A2) has no apparent protective 
effect on the proteolytic (chymotryptic or subtilisin) sus- 
ceptibility of either the 39-52 loop (a DNase I binding 
site), but that the segment between residues 61 and 69 of 
actin was strongly protected from proteolysis [145]. They 
therefore concluded that S-I(A2), whose alkali light chain 
lacks the 41-residue N-terminal extension present in MLC1, 
binds to the region 61-69 but has little or no involvement 
in the 39-52 region. They also showed that the binding 
constant for S-I(A2) for actin (1.2 x 106 M 1) was only 
slightly reduced (0.3 x 10 6 M 1) when actin was cleaved 
by subtilisin. 
A more recent report [109] confirmed that digestion of 
G-actin by subtilisin, chymotrypsin and trypsin was pro- 
tected by S-I(A2). However, digestion with ArgC pro- 
teinase produced an unexpected finding. They showed that 
G-actin is uniquely cleaved between Arg-39-His-40 and 
that this cleavage is protected in G-actin, but is exposed 
when S-I(A2) binds. They concluded that the structure of 
actin at or near residues 39-40 has a different conforma- 
tion in the monomeric state compared to either F-actin (see 
above) or when it binds S-I(A2). S-1 probably binds to 
subdomain-1 of one monomer and to subdomain-2 of the 
subjacent monomer along the same long-pitch strand i.e., 
towards the barbed end of the filament. They therefore 
proposed that S-1 binding to actin exposes 39-40, but 
protects 45-52 and 60-69 [109]. Their proposal seems 
most reasonable, particularly since Bonaf6 and her col- 
leagues recently reported a glutaraldehyde-mediated 
cross-linking to the myosin heavy chain (see below). 
The relationship between all of these cleavage points is 
summarized in Fig. 6 which shows that the proteolytic 
cleavage sites are mostly clustered in subdomain 2. 
A somewhat different approach was taken by Crosbie et 
al., who implicated the actin C-terminus in the binding of 
myosin [146]. They removed residues 369-375 with 
chymotrypsin and showed that these six residues are im- 
portant for the binding of caldesmon and, to a smaller 
extent, for S-1. S-1 binding protects these residues from 
proteolysis and a synthetic peptide based on this region of 
the actin sequence decreases the binding of caldesmon and 
S-1 to actin. They concluded that the C-terminus of actin is 
indirectly involved in S-1 binding. However, their experi- 
ments were not designed to establish if this was a myosin 
heavy chain- or light chain-mediated ffect. This result is 
consistent with the observations of Kouyama and Mihashi 
[147] who showed that the fluorescence of Cys-374-pyrene 
labelled actin was quenched (by about 70%) when S-1 
binds. In Fig. 5b we have assumed this to be an alkali light 
chain-mediated effect, but there are recent data which 
suggest that region (residues 338-348) may also be a 
myosin heavy chain binding site [103]. 
Non-polymerizable actin monomers complexed with S-1. 
Investigations of the binding of actin to myosin and the 
actin activation of myosin ATPase activity can be simpli- 
fied by studying the interaction of monomeric actin with 
S-1. Actin monomers can be stabilized by: (i) coupling to 
an insoluble matrix where they remain substantially native 
and still bind S-I even though they fail to activate myosin 
ATPase activity [148]; (ii) S-I(A2) binds to G-actin with- 
out strongly promoting its assembly under low salt condi- 
tions, probably because it does not facilitate the formation 
of trimer-actin uclei; (iii) the chemical cross-linker (m- 
maleimidobenzoyl N-hydroxysuccinimide (MBS) [149- 
151] creates an undefined intramonomer bond between a 
Cys and Lys in G-actin) which does not easily polymerize 
but which can reversibly bind to S-1 with a reasonable 
apparent dissociation constant (0.18-0.47 /zM) at low 
ionic strength [152]. Like unmodified G-actin [153], 
MBS-actin only weakly activates myosin ATPase activity 
and strong activation occurs only when the monomer is 
cross-linked to S-1 [151]; and finally (iiii) specific modifi- 
cations of particular amino acids inhibit polymerization 
(e.g., His-40 [123], Lys-61 [124], and Tyr-69 [50]). In 
addition, modification of other residues uch as Gin-41 has 
a mild inhibitory effect of actin assembly. Even modifica- 
tions of Cys-374 with large fluorescent probes change the 
rates of actin assembly and the extent of activation of 
myosin ATPase activity (see [154] and [95]). 
Arata [150] took these experiments o their next logical 
step. He compared the binding of myosin to MBS-actin 
and to inter-monomer c oss-linked (p-PDM-actin) actin 
dimers. The dimer formed a 1:1 complex with each myosin 
head but the monomeric actin formed a 2:1 (actin:S-1) 
complex suggesting there are probably two sites on each 
head which can bind to a single actin monomer. He 
reasoned that there actually may be three actin binding 
sites on each myosin head. One binds to F-actin, one binds 
to the stable monomer, and a third binds to the stable 
dimer in the presence of ATP. Binding to the third site 
may in some way block the first and second binding sites. 
S-1 binding affects the conformation of F-actin. FRET 
experiments with S-1 have demonstrated: (i) a decrease in 
the distance determined between Lys-61 and Cys-374 [48]; 
(ii) an increase in the Tyr-69-to-nucleotide istance [53]; 
and (iii) an increased radial coordinate of Gln-41 [91]. 
However, until 1993 there was no direct evidence to 
support he conclusion that S-1 induces a conformational 
change in monomeric actin. But in 1993, Kasprzak [66] 
found that the binding of S-I(A2) to monomeric actin 
significantly reduces the rates of both nucleotide and Ca 2 + 
exchange. Cleavage of actin by thrombin or removal of the 
C-terminal three residues did not significantly alter this 
conclusion. He suggested that the binding of S-1 to the 
small domain of actin may somehow inhibit the opening of 
the nucleotide cleft. 
Thus, there are several advantages in studying stable 
monomers of actin. They can determine the minimum 
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number of S-1 loci on each actin subunit (and vice versa). 
They also greatly simplify the interpretation of FRET 
experiments between actin and myosin because they avoid 
the potential for intermonomer nergy transfer in F-actin 
other than the one which makes contact with a labelled 
head. Finally, the stability of the monomer-S-1 complex 
has potential for generating crystals of the acto-S-1 com- 
plex. 
Nuclear magnetic resonance. NMR spectroscopy can 
sense a decrease in molecular motion protein ligands bind 
close to the label. We used 19F NMR and detected a high 
degree of rotational motion of 19F-labels covalently at- 
tached at Cys-10. We showed that when S-1 binds to 
labelled filaments there is a large reduction in the motion 
of this probe suggesting that S-1 binds at or close to 
Cys-10 [115]. This observation is consistent with other IH 
NMR data from the Trayer laboratory [155] showing that 
myosin light chain 1 attached to S-1 to the N-terminus of 
actin. 
Naturally-occurring actin mutants. The analysis of actin 
isoform sequences is complex and is summarized in a 
recent extensive review from John Sparrow's laboratory 
[27]. Except for the most primitive of the eukaryotes (e.g., 
yeasts), actins generally occur in multigene families, each 
individual carrying the genes for several isoforms as well 
as sometimes having more than one gene for the same 
isoform. For example, warm-blooded vertebrates all con- 
tain six isoforms [25]. About half of the amino- acid 
substitutions found in different known actin sequences 
reside in subdomain 1. At first glance it may seem para- 
doxical that this highly substituted subdomain should also 
be the major site for interaction with myosin. After all, one 
would guess that the S-1 binding sites on actin are func- 
tionally important and therefore should be preserved. Sub- 
domain 1 is also involved in binding most of the actin-bi- 
nding proteins (e.g., gelsolin, profilin, caldesmon) and the 
reader is referred to several recent reviews on this subject 
[25,27,101,130,142,156]. Muscle cr-actin sequences tend to 
be conserved as are the cytoplasmic (/3- and T-) actins 
isoforms. For example, it is probable that differences in the 
sequences of smooth and striated muscle actins rather than 
differences in myosins determine the functions of actin 
[88]. 
It is likely that amino acid substitutions in the first six 
residues are specific adaptations for interaction with myosin 
in muscle cells or binding to actin-binding proteins which 
are known to bind to this region of the cytoplasmic actins. 
In yeast, there is a single actin isoform which has only two 
(rather than four) N-terminal acidic residues and it acti- 
vates skeletal muscle myosin by only 5-10% of the effi- 
ciency of rabbit skeletal muscle actin [157]. In this way, 
muscle and non-muscle actin isoforms may be present 
together and carry out different functions and the incorpo- 
ration of nonmuscle isoforms into a sarcomere may be 
prevented because they are sequestered by actin binding 
proteins uch as thymosin f14. In a review of this subject, 
Rubenstein suggests that these systems may have evolved 
to allow homologous actins and myosins to interact in the 
presence of multiple actin isoforms [88]. 
Site-directed actin mutants which alter myosin func- 
tions. A number of laboratories have reported site-directed 
mutagenesis experiments aimed at understanding how the 
N-terminal four residues of actin interact with the heavy 
chain of S-1. Deletion mutants [158-160] or substitutions 
for non-charged amino acids [44,60,158-160] or oppo- 
sitely charged residues [44,158-161] all reduce the Vmax 
of the actin-activated myosin ATPase activity and slow 
actin filament velocity in motility assays [159,161,162] 
without altering the binding of S-1. Cook et al. [157] 
demonstrated that the addition of two extra negative charges 
at the N-terminus of yeast actin (see above) increases the 
actin-activated ATPase activity of myosin. Mutants involv- 
ing a more extensive neutralization of the Asp residues in 
the N-terminal component of subdomain 1 (Asp-2, Asp-24 
and Asp-25 in Dictyostelium; Asp-3 and Asp-4 in yeast) 
exhibit either a reduced or no activity in an ATP-driven 
motility assay [160-162]. However, there is no apparent 
effect on the ability of these mutant actins to polymerize, 
or to be Ca2+-regulated by the relaxing proteins. On the 
other hand, mutants near the C-terminus of subdomain-1 
(Glu-360, Glu-361 and Asp-363, Glu-364) are not essential 
for force generation, although there are apparently some 
kinetic effects when they are replaced with His [160]. 
Thus, it is clear that the N-terminus of actin must 
possess a negative charge if it is to activate myosin 
ATPase activity, but the precise number of negative charges 
is also important for the degree of activation. 
Synthetic peptides. The rotational motion of a synthetic 
peptide, PEPITC, attached to Cys-10, was severely im- 
paired by S-1 binding, and, in the absence of free ATP, 
binding of S-1 had little effect on this motion [163]. This 
finding was consistent with the findings of Miller et al. 
[99] summarized above. Van Eyk and Hodges found that a 
synthetic peptide of actin comprising residues 1-28 [164] 
competed with F-actin for the activation of S-1 ATPase 
activity. This suggested that the sequence 1-28 binds and 
activates both S-1 and HMM ATPase activity although this 
activation was not to the same extent observed for F-actin. 
Chaussepied and Kasprzak [165] devised an antipeptide 
(a short peptide with complementary charged to the native 
sequence) which mimics the binding of S-1 to actin. Their 
antipeptide-S-1 complex did not promote actin polymeriza- 
tion in the absence of salt. However, both the antipeptide 
and S-1 were still able to bind to actin filaments and they 
concluded there is a conformational change in actin when 
it polymerizes which generates new actin binding sites in 
F-actin. 
Kogler et al. [166] reported that a substantial fragment 
of actin (residues 1-44) had an activating effect on the S-1 
ATPase activity. This effect was weak, but it appeared to 
be very specific. It was obtained by cyanogen bromide 
cleavage of actin and was isolated by gel filtration and ion 
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exchange chromatography. Two other peptides (residues 
1-18 and 83-119) had no detectable ffect. These authors 
were unable to determine whether esidues 1-32 or residues 
33-44 are as effective as 1-44. In terms of actin domains, 
this finding suggests that parts of subdomain 1 and/or 
subdomain 2 are necessary for the ATPase-activating ef- 
fect of actin. 
Cartoux et al. adopted a different approach [167]. They 
demonstrated that the binding of a seven residue peptide 
(containing a net positive charge) to actin inhibits the 
actin-activation of myosin ATPase activity. In contrast o 
the anti-l-7 antibodies, peptides based on the sequence 
around SH1 peptide of S-1 (its most reactive sulfhydryl), 
did not reverse the protective ffect of F-actin on the SH1 
site. Moreover, the antibodies failed to decreased the bind- 
ing of the SH1 peptide to actin. These authors concluded 
that the N-terminus of actin interacts only indirectly with 
SH1. 
S-1 induces conformational changes in the small subdo- 
main ofactin. In 1992, Chen et al. [145] probed this region 
using limited digestion in the presence and absence of 
S-I(A2). They concluded that DNase I and S-I(A2) bind 
to distinctly different sites in subdomain 2. Later, we [46] 
observed that the distance between Gin-41 on one monomer 
and Cys-374 on an adjacent monomer is significantly 
affected by the binding of S-1 while the distance between 
Cys-374 and the nucleotide (using E-ATP as a probe of 
this locus) was effectively unchanged. This implies a 
mobility in subdomain 2 but not in subdomain 1 when S-1 
binds. The combination of X-ray diffraction and cryo-elec- 
tron microscopy [7,73] have implicated residues 40-42 as 
being close enough to bind to myosin S-1. Thus, Gin-41 
probably resides at an actin-actin contact site which is 
close to an S-1 binding site. This conclusion is consistent 
with the recent report that DNase I increases the dissocia- 
tion constant of G-actin-S-1 by a factor of 4-5 [85]. 
In 1994 Bonaf~ et al. demonstrated [103] that residues 
48-67 and particularly Lys-50 in subdomain 2 can be 
cross-linked to the S-1 heavy chain using glutaraldehyde 
and that this link was abolished in the presence of 
tropomyosin. They also showed that glutaraldehyde cross- 
links Arg-28 in subdomain 1 to the S-1 heavy chain, but 
that this interaction is not sensitive to tropomyosin bind- 
ing. 
Prochniewicz-Nakayama and Yanagida [128] cross-lin- 
ked G- and F-actin and studied their effects on a HMM- 
based actin motility assay. They determined HMM Km 
values for various chemical cross-linkers (EDC, disuccin- 
imidyl suberimidate and glutaraldehyde) and showed that 
actin filaments formed from glutaraldehyde cross-linked 
actin lost their ability to support he motility assay. Again, 
the conclusion was that conformational changes may be 
important for actin function. 
Subdomain 3 and the 'Hinge'. While it is apparent that 
the major contact sites of S-1 with actin occur in subdo- 
main 1 and to a lesser extent in subdomain 2 there is a 
proposal [9] that subdomain 3 or at least the 'hinge' 
between subdomains 1 and 3 may also play a part. This 
may mean that S-1 can progressively move across the 
'front' face of actin. In the Holmes et al. model this would 
imply that S-1 'penetrates' deeper than thought towards 
the actin filament axis (Fig. 3). Alternatively, the Schutt et 
al. model might interpret this as moving along the filament 
axis towards the subjacent monomer in the filament (Fig. 
4). 
Does each myosin head bind one or two actin monomers. 
As early as 1975 Chantler and Gratzer [50] observed that 
the F-actin activation of myosin ATPase activity by native 
and chemically modified monomers was not proportional 
to the fraction of native monomers, and they concluded 
that the myosin heads interacted with more than one actin 
subunit. In 1981 Mornet et al. combined trypsin cleavage 
with zero-length cross-linkers to show by gel electrophore- 
sis that two adjacent monomers can simultaneously bind to 
the S-1 heavy chain [168]. At this time there was already 
ample evidence to show that saturation binding of F-actin 
by S-1 occurred at a 1:1 molar ratio [134,169], but this was 
not necessarily inconsistent with a model in which two 
S-Is bind to the same two actin monomers. The binding 
stoichiometry and the saturation effects of S-1 was re-ex- 
amined in publications by Sutoh [170], Chen et al. [171] 
and others, who concluded that only one actin was bound 
to each S-1 heavy chain. More recently, the question came 
to a 'head' once again with the reports by Andreev, 
Borejdo and colleagues [172,173] who suggested that bind- 
ing in the rigor state may well depend on the availability 
of actin monomers, i.e., on whether S-1 fragments saturate 
all available monomers. They argued that conditions in 
vitro can be easily arranged so that one myosin head (S-I) 
binds to each actin monomer of F-actin whereas in vivo 
there is always an excess of myofibrillar actins over 
myosin heads so that saturation binding is prevented. They 
proposed a two-stage rigor complex in which each S-1 
initially binds rapidly to one monomer followed by a slow 
binding stage where each S-1 binds to a second actin only 
if it is unoccupied. This scheme differs from the idea of a 
single actin-S-1 heavy chain connection as well as a 
contact between actin and myosin light chain 1 visualized 
by Milligan et al. [73], because they had saturated F-actin 
with S-I, leaving no opportunity for the Borejdo binding 
effect. 
Does a myosin head affect the conformation of  more 
than one actin monomer? Two observations provide a 
possible solution to this question. In a preliminary observa- 
tion, Ishiwata et al. (Ishiwata, S., Miki, M., Funatsu, T. 
and Dos Remedios, C.G. (1991) Proc. Japan. Biophys. 
Soc. p. 293) used FRET spectroscopy to probe the distance 
between SH1 loci of adjacent S-1 heads bound to actin. 
Energy transfer was observed between these loci only 
when the S-1 fragments were close-packed on a thin 
filament. No transfer was observed between the heads of 
HMM-decorated F-actin. Rigor conditions (when myosin 
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heads were strongly bound) were essential for transfer and 
none was seen under low salt-ATP solvent conditions 
equivalent to the weak binding site. 
This observation can be combined with the fact that 
actin monomers exhibit a random variable twist [174]. S-1 
has several surface 'patches' which make contact with one 
actin monomer and at least one other site which attaches to 
a subjacent monomer [175]. Thus, while a myosin head 
forms a major contact with one actin monomer, it probably 
also spends at least part of the crossbridge cycle attached 
between two adjacent monomers along the long-pitch actin 
helix [73]. The N-terminus of myosin light chain 1 proba- 
bly effects this contact and probably explains why S-I(A1) 
but not S-I(A2) accelerates actin assembly [144] particu- 
larly under 'weak' binding conditions. Binding such as 
this will probably alter the rotational flexibility of these 
monomers [176] and restrict he rotational motion of adja- 
cent monomers. This restriction is likely to affect the 
rotational freedom of other adjacent monomers and may 
well account for the propagated structural change induced 
by S-1 reported by Ando [177] and other authors. 
Non-saturating behavior of S-1 on F-actin. At the 1972 
Cold Spring Harbor Symposium, Oosawa et al. [87] re- 
ported that the binding of HMM heads altered the fluores- 
cence intensity of labelled F-actin in a non-saturating way, 
i.e., the effect saturated when only 20% of the myosin 
heads were bound. Around the same time, others [178] 
showed that the binding of HMM increased the flexibility 
of F-actin and that the effect saturates at a ratio of about 
1:6 HMM:actin. Ando [177] demonstrated this effect in a 
more subtle way. He showed that the cross-linking of a 
myosin head (S-I) to an actin monomer altered the confor- 
mation of nearby monomers o as to reduce their affinity 
for the S-1-ADP-P i complex. These and other data suggest 
that actin conformation is altered by the direct binding of a 
myosin head and that the conformations of adjacent 
monomers are also affected. 
General conclusions. The contacts between actin and 
S-1 involves more than just a few amino acids. Table 2 
provides ample evidence that S-1 binds to multiple sites 
within subdomains 1 and 2 of actin and the 'hinge' 
between the large and small domains. The N-terminal 11 
residues eem to be involved in the 'weak' binding state in 
the presence of Mg-ATP, but play little or no part in the 
contact under rigor conditions. Residues 1-11 and 18-28 
are important for the actin activation of myosin ATPase 
activity and for the movement of actin filaments in a 
motility assay. The available evidence suggests that 
residues 1-4, 11, 18-29, 40-52, 60-69, 79-92, 95-103, 
112-125, 144, 332-334, 341-352 and 360-364 can make 
contact with the myosin head at some stage during the 
cycle of cross-bridge interaction. 
Thus, our view of the interaction between S-1 and 
F-actin begins with a positively-charged, mobile 'feeler' 
myosin peptide (residues 626-647) which perhaps 'docks' 
with the negatively-charged, mobile N-terminal (residues 
1-11) of actin. This 'weak' contact with the mobile part of 
subdomain 1 is followed by a stronger contact in which the 
S-I movement may involve a progression from 1-7 (weak) 
to 18-29 (strong) within subdomain 1 or S-1 m~iy progres- 
sively moves across subdomain 1 over the 'hinge' (i.e., 
residues 144 and 332-334) towards the subdomain 3 (i.e., 
residues 341-352). 
S-1 binds to a second class of actin loci which may be 
located at the 'back' of the subjacent monomer, perhaps 
making contact with residues 40-52 at the 'top' of subdo- 
main 2 which may flex or rotate away from the position 
shown in Fig. 1. Residues 105-125 on the back of subdo- 
main 1 probably bind directly to the myosin heavy chain. 
In adddition, the alkali light chain contacts may involve 
residues 360-364 and 374 at the C-terminus on the 'back' 
of subdomain 1, probably on an adjacent monomer. 
This description of progressive and multiple contacts 
between S-1 and the actin filament is entirely consistent 
with the proposal by Andrew Huxley and Bob Simmons 
[179], namely that S-1 may transiently 'dock' and then 
'rock' into progressively more stable positions before the 
head is dissociated by the binding of a Mg-ATP at the start 
of a new cross-bridge cycle. 
7. Addendum 
After this review was prepared for publication, we 
became aware of a far more extensive compendium in the 
Protein Profile Series on actin by Peter Sheterline and John 
Sparrow [34]. In particular, this substantial document re- 
views areas of actin research that are not covered by the 
present review. These include: purification of actins from 
various sources; the comparative ( volutionary) sequence 
data on actins; an extensive review of actin-binding and 
actin-like proteins; the molecular genetic manipulation of 
actin; drug and toxin binding; and the interaction of actin 
with the regulatory proteins. 
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